Przeciwciało anty-PDGFR alfa do zastosowania w leczeniu przerzutowego raka kości

• 收藏
• 分享

专利权人:

Philadelphia Health and Education Corporation d/b/a Drexel University College of Medicine;ImClone LLC

发明人:

LOIZOS, NICK,DOLLOFF, NATHAN GRAEME,FATATIS, ALESSANDRO

申请号：

PL09075102

公开号：

PL2100618T3

申请日:

2006.06.19

申请国别(地区):

PL

年份:

2014

代理人:

摘要：

The present invention concerns an effective amount of a PDGFR± antagonist for use as a medicament for treating subjects having a bone tumor and also for inhibiting growth of a bone tumor. The PDGFR± antagonist may be an antibody or antibody fragment. In certain embodiments the antagonist can be a bispecific antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/